“The market of biological medicines and biosimilars”
On March 1, 2023, within the framework of a series of guest lectures by stakeholders for higher education students “Industrial Biotechnology”, the head of the oncology department of Pfizer, Oleksandr Kayota, was invited to give a lecture “The market of Read more